GLP-1 drugs work for weight loss, study finds

Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
America’s love-hate relationship with the new weight-loss drugs
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls significantly when they learn that the weight might come back when the meds are stopped.
Some GLP-1s Achieve More Weight Loss Than Others: Study
We found that, of the 12 GLP-1 (drugs) identified by our search, the greatest mean body weight reduction was reported in randomized controlled trials of retatrutide, tirzepatid
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
Magic shots for weight loss? Why everyone's talking about these drugs; know health benefits and risks
Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight ...
Medscape21d
A New Weight Loss Drug With No Side Effects? Yes…So Far
Another big one is muscle loss. A new ... weight loss,” Gerhart-Hines said. He explained that GLP-1 agonists don’t work quite as well for weight loss in people with diabetes because the ...
FierceBiotech1d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
The Washington Post1mon
Age and the new weight-loss drugs
Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy ... Center at Weill Cornell Medicine in New York City. This helps control blood sugar.
Professor Tim Spector issues weight loss jab food warning
Professor Tim Spector and his Zoe co-founder Jonathan Wolf have issued advice for those looking to change their diets in the ...
Yahoo Finance19d
Novo Nordisk's New Weight-Loss Drug Lags Behind Eli Lilly's Zepbound
Novo Nordisk (NYSE:NVO)'s new weight loss drug CagriSema missed the company's target of reducing at least 25% body weight of the Phase 3 trials' participants. CagriSema only showed an ...
Reuters21d
Nestle launches protein shots for US weight-loss drug users
LONDON, Dec 18 (Reuters) - Nestle (NESN.S), opens new tab is launching ... Nestle. The shot, whose formula Nestle has patented, is not intended to replace weight loss drugs and is less ...
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
New York Post27d
1 in 6 people plan to skip their weight-loss drugs over the holidays so they can eat more
About 12% of US users of drugs like Ozempic and Wegovy ... medical content lead at Levity, an online weight-loss management service that conducted the new poll of 1,000 US and UK residents.
MarketWatch19d
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from a late-stage trial showed that the Danish company’s new weight-loss ...
FDA issues draft guidance on developing weight loss drugs
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...